The Meteoric Rise of Digital Therapeutic, Monitoring and Diagnostic Solutions

Chronic disorders, such as diabetes, heart disease, obesity, mental health problems and insomnia, are considered to be the leading causes of death and disability across the world.  According to a 2018 report published by the Center for Managing Chronic Disease at the University of Michigan, more than 50% of the global population currently lives with some form of chronic disease. Digital healthcare, a relatively new concept, is believed to possess the potential to address the rising concerns related to this growing socio-economic burden. Driven by the demand for self-management approaches, personalized healthcare solutions and customized treatment regimens made available in the home-care setting, digital health companies are presently engaged in developing several innovative solutions for therapeutic, surveillance and diagnostic use.

With the goal to manage rising monetary burden on healthcare systems worldwide, over 100 digital health companies, with innovative solutions, have surfaced recently

As per Roots Analysis, over 40% of the digital therapeutics, monitoring and diagnostic solutions utilizes standalone software application.

150+ digital solutions are being evaluated across various stages of development for diverse chronic diseases; most developers are based in North America.

Case-in-point: Metabolic disorders, being targeted by close to 30% of digital therapeutics, has emerged as the key focus area.

More than 50% of digital therapeutics are software applications, which are offered either as standalone solutions or in combination with a personal coach and / or a device.

Foreseeing the future potential, a total investment of close to USD 2.8 billion has been made into this domain since 2011.

70+ stakeholders have entered into collaborations with research institutes and big pharmaceutical companies to establish new standards for digital solutions

Various Industry and Non-industry players have inked various deals where over 15% of the partnerships were focused on marketing and distribution

In the quest for an effective go-to-market strategy, players have focused on highlighting key features of their solutions across a range of marketing / distribution platforms.

With the opportunity spread across different therapeutic areas and distribution channels, the market for digital health solutions is anticipated to grow at a CAGR of over 15.4%.

Standalone software solutions are anticipated to lead the pack in the short-midterm; companies based in Asia-Pacific are expected to gradually gain a higher market share

The overall market for digital therapeutics is expected to grow at a CAGR of 15% by 2030. Further, North America is expected to capture the highest share.

To learn more, please click Digital Health Digital Therapeutic Diagnostics solutions market. For any queries / suggestions, please do not hesitate to contact us at

Our Social Media Platform